House Members Push FDA, CMS on Biosimilars Guidance, Billing By Sam | March 8, 2016 House members are growing impatient with the FDA over a lack of guidance on biosimilars, with several venting their frustrations during a hearing last month. Source: Generic Line Posted in Generic Line